This book is an exploration of issues that are essential in end of life care. Understanding end of life practices across cultures and religions is important in the delivery of patient centered end of life care. This book helps clinicians and non-clinicians understand the various end of life practices in their vast patient populations, further contributing to providing empathetic and compassionate end of life care to patients. With the advent of many new options at the end of life, this book also explores the modern day approaches to end of life often sought by patients when faced with...
This book is an exploration of issues that are essential in end of life care. Understanding end of life practices across cultures and religions is ...
This book aims to provide threshold models to help physicians to make optimal diagnostic, therapeutic and predictive decisions. Readers will not only find theoretical information but also practical examples illustrating how these decisions should be made.
Poor decision-making is considered a leading cause of death in contemporary medicine. Decisions, however, have to be made - at a given threshold of risk and unfortunately physicians are not trained on how to make decisions. This book provides help to all those who want to improve their decision-making for a better patient...
This book aims to provide threshold models to help physicians to make optimal diagnostic, therapeutic and predictive decisions. Readers will not on...
This book discusses the latest developments in Poly (ADP-ribose) polymerase (PARP) inhibitor drug development. It focuses on the translational and clinical development of the latest drugs, as well as the evidence for regulatory approval of PARP inhibitors in multiple different molecular subtypes and tumor indications. The most-up-to-date information on basic scientific research on DNA repair pathways and the DNA Damage Response (DDR) is also covered. Every chapter contains insight into the preclinical, translational along with clinical aspects of a specific DDR inhibitor with key and...
This book discusses the latest developments in Poly (ADP-ribose) polymerase (PARP) inhibitor drug development. It focuses on the translational and cli...
This book addresses Epigenetics in Cancer and covers the most recent advances in RNA/histone/DNA epigenetics in Oncology. RNA/histone/DNA epigenetics have been shown to play pivotal roles in cancer initiation, progression, maintenance and drug response/resistance, tumor microenvironment, cancer stem cell self-renewal, cancer metabolism, and tumor immune evasion. In particular, research in RNA cancer epigenetics has made impressive progress in the last few years.
Individual chapters in Part I (focusing on RNA epigenetics) are devoted to RNA modifications in Cancer Metabolism and...
This book addresses Epigenetics in Cancer and covers the most recent advances in RNA/histone/DNA epigenetics in Oncology. RNA/histone/DNA epigeneti...
This book focuses on innovative treatment options for breast cancer, including surgery, radiotherapy, systemic therapy and of course immunotherapy that is changing outcomes in some aggressive breast cancer histotypes. Subsequent chapters also address the ongoing emerging research in the screening, diagnostics, and management of all subtypes of breast cancers. All current landscapes and future perspectives in each molecular subtype: luminal, HER2-positive, and triple-negative breast cancers are discussed within the different chapters.
Breast cancer is still the...
This book focuses on innovative treatment options for breast cancer, including surgery, radiotherapy, systemic therapy and of course immunotherap...